Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies

Chart review (n=136, US) found frequency of mTOR inhibitor linked stomatitis similar to previously reported, with 1/3 patients with vascular anomalies experiencing mucosal toxicities. Topical treatments show variable degrees of success; dose reduction frequently improves symptoms

Source:

JAMA Dermatology